Acquired factor V inhibitor: Aetiology, bleeding risk and treatment with regard to three cases;Anticoagulant acquis antifacteur V: Nosologie, risque hémorragique et prise en charge thérapeutique à propos de trois observations

Revue de Medecine Interne

Volumn 22, Issue 11, 2001, Pages 1119-1123

  Schleinitz, N ^a   Veit, V ^a   Chouquet, D ^a   Seux, V ^a   Arnoux, D ^a   Mokart, D ^b   Lelong, B ^b   Alessi, M C ^c   Kaplanski, G ^a   Harle J R ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Bleeding; Factor V inhibitor; Intravenous immunoglobulins

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 INHIBITOR; IMMUNOGLOBULIN; THROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PATHOGENESIS; PLASMAPHERESIS; THROMBOCYTE TRANSFUSION;

EID: 17744416477     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00477-5     Document Type: Article

References (23)

1. Acquired factor V inhibitors
2. Acquired inhibitors of factor V
3. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions
4. Immune complexes containing factor V in a patient with an acquired neutralizing antibody
5. Isolation and study of an acquired inhibitor of human coagulation factor V
6. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations
7. Fibrin glue in surgery: Frequent development of inhibitors of bovine thrombin and human factor V
8. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin
9. Inhibitor to factor V in severe factor V congenital deficiency. A case report
10. Bleeding due to an acquired inhibitor of platelet associated factor V
11. AL amyloidosis combined with acquired factor V deficiency
12. Factor V inhibitor associated with Sjogren's syndrome
13. Anti-factor V acquired circulating anticoagulant in rheumatoid arthritis
14. Factor V-specific circulating anticoagulant and enteropathy. 2 cases
15. Study on an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid
16. Acquired circulating anticoagulant with anti-factor V activity in AIDS: First case report
17. Acquired factor V inhibitor in a patient with acquired human immunodeficiency syndrome
18. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin
19. Acquired factor V inhibitor treated with intravenous immunoglobulins
20. A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study
21. The response of an acquired Factor V inhibitor to activated factor IX concentrate
22. Multimodality therapy of an acquired factor V inhibitor
23. Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression